Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Rivopharm UK Ltd., 30<sup>th</sup> Floor, 40 Bank Street, Canary Wharf, London, El4 5NR, United Kingdom
Clindamycin 150 mg capsules, hard.
| Pharmaceutical Form |
|---|
|
Capsule. Clindamycin capsules are white/white hard capsules with a marking of ‘CLIN 150’ on the capsule body. |
Each capsule contains: clindamycin hydrochloride equivalent to 150 mg clindamycin.
Excipient with known effect: 214 mg lactose/Clindamycin 150 mg capsules.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
| List of Excipients |
|---|
|
Lactose monohydrate |
The blister pack (PVC/aluminium) contains 24, 30, 32, 40 or 100 tablets, respectively.
Not all pack sizes may be marketed.
Rivopharm UK Ltd., 30th Floor, 40 Bank Street, Canary Wharf, London, El4 5NR, United Kingdom
PL 33155/0009
22/11/2010
| Drug | Countries | |
|---|---|---|
| CLINDAMYCIN | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.